Akihiro Kawasaki

Advised numerous Japanese listed companies on Japanese anti-CFC rules related to outbound investment and overseas restructuring.

Advised numerous Japanese companies on investments in US- and/or Europe-based real estate investment funds.

Advised numerous Japanese listed companies on Japan-China cross-border restructuring.

Represented numerous subsidiaries of foreign MNCs in Tokyo Regional Taxation Bureau tax examinations (e.g. with regard to permanent establishment, Japanese Consumption Tax (JCT) and CFC rules, etc.)

Advised a Japanese listed company on the de-SPAC listing of its Israeli subsidiary on NASDAQ.

Advised numerous foreign MNCs, including US SEC-listed pharmaceutical companies, on domestic reorganization.

Advised numerous foreign MNCs on JCT matters.

Advised numerous foreign MNCs on setting up Japanese subsidiaries.

Advised a foreign MNC on tax structuring in connection with its investment in renewable energy facilities.

Advised a foreign medical device company on obtaining a determination by the National Tax Agency with regard to its tax treaty application.

Advised a Japanese company on its stock listing in Hong Kong.

Advised Japanese companies on virtual currency issues.